These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 424003)

  • 1. The anti-nociceptive effect of reserpine and haloperidol mediated by the nigro-striatal system: antagonism by naloxone.
    Heinz G; Jurna I
    Naunyn Schmiedebergs Arch Pharmacol; 1979 Jan; 306(1):97-100. PubMed ID: 424003
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of morphine on the accumulation of DOPA after decarboxylase inhibition in the rat.
    Persson SA
    Eur J Pharmacol; 1979 Apr; 55(2):121-8. PubMed ID: 456411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of substantia negra stimulation and morphine on alpha-motoneurones and the tail-flick response.
    Jurna I; Heinz G; Blinn G; Nell T
    Eur J Pharmacol; 1978 Oct; 51(3):239-50. PubMed ID: 710502
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of morphine and haloperidol on the electrical activity of rat nigrostriatal neurons.
    Iwatsubo K; Clouet DH
    J Pharmacol Exp Ther; 1977 Aug; 202(2):429-36. PubMed ID: 886472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of LSD and 2-bromo LSD on the striatal DOPA accumulation after decarboxylase inhibition in rats.
    Persson SA
    Eur J Pharmacol; 1977 May; 43(1):73-83. PubMed ID: 16756
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-nociceptive effect of morphine, opioid analgesics and haloperidol injected into the caudate nucleus of the rat.
    Jurna I; Heinz G
    Naunyn Schmiedebergs Arch Pharmacol; 1979 Nov; 309(2):145-51. PubMed ID: 522900
    [No Abstract]   [Full Text] [Related]  

  • 7. Evidence for a role of endogenous opioids in the nigrostriatal system: influence of naloxone and morphine on nigrostriatal dopaminergic supersensitivity.
    Hirschhorn ID; Hittner D; Gardner EL; Cubells J; Makman MH
    Brain Res; 1983 Jun; 270(1):109-17. PubMed ID: 6409355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Morphine-induced striatal dopamine efflux depends on the activity of nigrostriatal dopamine neurones.
    Moleman P; Bruinvels J
    Nature; 1979 Oct; 281(5733):686-7. PubMed ID: 551287
    [No Abstract]   [Full Text] [Related]  

  • 9. Evidence that opioid receptors in the substantia nigra pars reticulata are relevant in regulating the function of striatal efferent pathways.
    Turski L; Havemann U; Kuschinsky K
    Behav Brain Res; 1982 Aug; 5(4):415-22. PubMed ID: 6289848
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Morphine suppression of substantia nigra zona reticulata neurons in the rat: implicated role for a novel striatonigral feedback mechanism.
    Finnerty EP; Chan SH
    Eur J Pharmacol; 1979 Nov; 59(3-4):307-10. PubMed ID: 527651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Neurophysiologic and pharmacologic evidence of autoregulationin the nigrostriatal system].
    Arushanian EB; Tolpyshev BA
    Biull Eksp Biol Med; 1981 Feb; 91(2):133-6. PubMed ID: 7194700
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of interruption of the nigrostriatal pathway and of dopaminergic agents on the spontaneous activity of globus pallidus neurons in the awake monkey.
    Filion M
    Brain Res; 1979 Dec; 178(2-3):425-41. PubMed ID: 116713
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The response of non-dopamine neurons in substantia nigra and ventral tegmental area to amphetamine and apomorphine during hypermotility: the striatal influence.
    Olds ME
    Brain Res; 1988 Jun; 452(1-2):237-54. PubMed ID: 3401732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of systemic and intrastriatal injections of haloperidol on striatal dopamine and DOPAC concentrations in rats pretreated by section of nigrostriatal fibres.
    Wuerthele SM; Moore KE
    J Pharm Pharmacol; 1980 Jul; 32(7):507-10. PubMed ID: 6105192
    [No Abstract]   [Full Text] [Related]  

  • 15. Reserpine pretreatment prevents increases in extracellular striatal dopamine following L-DOPA administration in rats with nigrostriatal denervation.
    Kannari K; Tanaka H; Maeda T; Tomiyama M; Suda T; Matsunaga M
    J Neurochem; 2000 Jan; 74(1):263-9. PubMed ID: 10617128
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of dopaminergic stimulation and blockade on the nociceptive and antinociceptive responses of mice.
    Tulunay FC; Sparber SB; Takemori AE
    Eur J Pharmacol; 1975 Aug; 33(1):65-70. PubMed ID: 1175692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dopamine-glutamate interactions in the striatum: behaviourally relevant modification of excitotoxicity by dopamine receptor-mediated mechanisms.
    Garside S; Furtado JC; Mazurek MF
    Neuroscience; 1996 Dec; 75(4):1065-74. PubMed ID: 8938742
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of the nucleus accumbens and nigrostriatum in enkephalin-induced myoclonus.
    Dzoljic MR; van der Poel-Heisterkamp AL
    Pharmacol Biochem Behav; 1980 Jul; 13(1):103-6. PubMed ID: 6773072
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increase of striatal dopamine turnover by drugs: interference with granular storage or receptor blackade?
    Saner A; Pletscher A
    Eur J Pharmacol; 1977 Mar; 42(2):155-60. PubMed ID: 844496
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rotational behavior induced by unilateral electrical stimulations of nigro-striatal dopamine neurons: modification by low doses of apomorphine.
    Barghon R; Costentin JH
    Eur J Pharmacol; 1980 May; 64(1):39-46. PubMed ID: 6969658
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.